Industry Antiseptic Literature Review Does Not Support Benefit – FDA
This article was originally published in The Rose Sheet
Executive Summary
The 155 literature assessments submitted to FDA by the Cosmetic, Toiletry and Fragrance Association to support a clinical benefit from the use of OTC healthcare antiseptics present too broad a variation in methods that "confounds the assessment of the contribution of OTC healthcare antiseptics to infection control," the agency says
You may also be interested in...
CTFA Antiseptic Log Reduction Criteria Will Be Topic Of NDAC Meeting
A request from the Cosmetic, Toiletry and Fragrance Association to FDA's Division of Over-The-Counter Drug Products to consider reducing the current log reduction criteria used to measure the efficacy of topical antiseptic products will be discussed at a March 23 meeting of the Nonprescription Drugs Advisory Committee in Gaithersburg, Md
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program